About Us:

Endo Pharmaceuticals (OTC: ENDPQ) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them. Learn more at Endo.com or connect with us on Linkedln.


1400 Atwater Drive

Malvern, PA 19355



Brief summary of the
materials and/or video content:

SUPPRELIN LA (histrelin acetate) subcutaneous implant has been used for over a decade and prescribed by pediatric endocrinologists.

To learn more about the implantation procedure, watch an experienced peer perform an in-office implant procedure at procedurevideo.com and use the following credentials (case sensitive) to log in:

Username: HCP
Password: procedure

Please see Important Safety Information at SupprelinLA.com/hcp

Please see full Prescribing Information for SUPPRELIN® LA.

SP-05786/April 2023



Have questions? Please contact:

For all other enquiries please contact us at https://www.endo.com/endopharma/contact-us

Enter the MAP Spotlight Raffle